Merlin BioMed Group Overview

  • Investor Type
  • Venture Capital

  • Status
  • Inactive

  • Investments
  • 41

  • Portfolio
  • 1

  • Exits
  • 32


Merlin BioMed Group General Information

Company Description

Merlin BioMed Group was venture capital firm which used to invest in the biotechnology, pharmaceuticals, medical devices and healthcare care sectors.

Business Details

Year Founded
Investor Status
Out of Business
Primary Investor Type
Venture Capital
Corporate Office
  • 230 Park Avenue
  • Suite 928
  • New York, NY 10169
  • United States
+1 (212) 000-0000

Merlin BioMed Group Investments (41)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
LK Technology Importacao E Exportacao 17-Jul-2013 Buyout/LBO 00000 Distributors (Healthcare) Profitable
Palatin Technologies 05-Jul-2012 0000 000.00 Biotechnology Generating Revenue/Not Profitable
Euthymics Bioscience 30-May-2012 0000 0000 Drug Discovery Generating Revenue
Gemin X Pharmaceuticals 04-Aug-2010 00000 00000 000 Pharmaceuticals Clinical Trials - Phase 2
PhotoMedex 23-Oct-2009 0000 00.00 Surgical Devices Generating Revenue
Calypso Medical 24-Sep-2009 00000 00000 0000 Diagnostic Equipment Generating Revenue
CymaBay Therapeutics 06-Sep-2009 00000 00000 00.00 Biotechnology Generating Revenue/Not Profitable
Ventaira Pharmaceuticals 12-Jun-2007 00000000000 00000 Drug Discovery Generating Revenue
AVEO Oncology 03-May-2007 Later Stage VC 0000 Biotechnology Generating Revenue
Calypso Medical 21-Dec-2006 Later Stage VC 000.00 Diagnostic Equipment Generating Revenue
You’re viewing 10 of 41 investments. Get the full list »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Merlin BioMed Group Exits (32)

Company Name Exit Date Exit Type Exit Size
Euthymics Bioscience 01-Nov-2017 Merger/Acquisition
Bioject Medical Technologies 29-Apr-2016 000000000000000000 00.00
FibroGen 14-Nov-2014 000 00000
RenaMed Biologics 01-Aug-2014 0000000000: 000000
CymaBay Therapeutics 27-Jan-2014 000
Nabi Biopharmaceuticals 09-Nov-2012 000000000000000000
Tapestry Pharmaceuticals 25-Apr-2012 000 00 00000000
Neurologix 19-Mar-2012 0000000000: 000000
AGI Therapeutics 02-Feb-2012 Merger/Acquisition
Calypso Medical 19-Sep-2011 Merger/Acquisition 000.00
You’re viewing 10 of 32 exits. Get the full list »

Merlin BioMed Group Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Merlin BioMed Group FAQs

  • What is Merlin BioMed Group?

    Merlin BioMed Group was venture capital firm which used to invest in the biotechnology, pharmaceuticals, medical devices and healthcare care sectors.

  • When was Merlin BioMed Group founded?

    Merlin BioMed Group was founded in 1998.

  • Who is the founder of Merlin BioMed Group?

    Stuart Weisbrod Ph.D is the founder of Merlin BioMed Group.

  • Where is Merlin BioMed Group headquartered?

    Merlin BioMed Group is headquartered in New York, NY.

  • How many investments has Merlin BioMed Group made?

    Merlin BioMed Group has made 41 investments.

  • What has Merlin BioMed Group invested in?

    Merlin BioMed Group has made numerous investments in companies like LK Technology Importacao E Exportacao, Palatin Technologies, and Euthymics Bioscience within the Distributors (Healthcare), Biotechnology, and Drug Discovery industries.

  • What has Merlin BioMed Group invested in recently?

    Merlin BioMed Group's latest investment was on 17-Jul-2013 in LK Technology Importacao E Exportacao, a company within the Distributors (Healthcare) industry.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »